What 2020 means for the life sciences
BIO 2020: AI patents and secrets
Andrii Vodolazhskyi / Shutterstock.com
As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.
Nine days before the World Health Organization officially notified the public of a flu-like outbreak in China, BlueDot, a Canadian artificial intelligence (AI) startup, warned its clients of a potential outbreak near a market in Wuhan, China.
On December 31, 2019, BlueDot, using machine learning and natural-language processing to scour through foreign language news reports and medical bulletins in many languages, alerted public health officials in Canada and elsewhere of the outbreak and identified the countries that were most at risk, based on airline ticket data.
Breaking new ground
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
IPOS International, COVID-19, WHO, artificial intelligence, machine learning, Alibaba, pandemic, patents, innovation, healthcare, software, trade secrets